GE HealthCare Technologies Inc. - Common Stock (GEHC)
60.76
-1.91 (-3.05%)
NASDAQ· Last Trade: May 17th, 9:30 AM EDT
Detailed Quote
Previous Close
62.67
Open
62.37
Bid
60.76
Ask
60.87
Day's Range
60.67 - 62.64
52 Week Range
58.75 - 89.77
Volume
4,777,454
Market Cap
27.59B
PE Ratio (TTM)
12.55
EPS (TTM)
4.8
Dividend & Yield
0.1400 (0.23%)
1 Month Average Volume
6,090,040
Chart
About GE HealthCare Technologies Inc. - Common Stock (GEHC)
GE HealthCare Technologies Inc. is a leading global medical technology and digital solutions innovator focused on improving patient outcomes through advanced healthcare solutions. The company develops and manufactures a wide range of diagnostic imaging systems, monitoring devices, and healthcare IT services that empower healthcare providers to deliver accurate and efficient patient care. Through its commitment to innovation, GE HealthCare supports clinicians and patients by providing tools that enhance diagnostic capabilities, streamline workflows, and facilitate data-driven decision-making in an increasingly complex healthcare environment. Read More
GE HealthCare Technologies (NASDAQ:GEHC) executives said the company remains confident in its long-term growth prospects despite a disappointing first quarter that led to a reduction in full-year guidance, citing inflationary cost pressures as the primary near-term challenge.
Speaking at a Bank of
The Law Offices of Frank R. Cruz announces an investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC) on behalf of investors concerning the Company’s possible violations of federal securities laws.
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In GE HealthCare (GEHC) To Contact Him Directly To Discuss Their Options
The law firm of Kirby McInerney LLP is investigating potential claims against GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (Nasdaq: GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company’s presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care.
As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (Nasdaq: GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements.
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
GE HealthCare’s first quarter was marked by strong revenue growth from its pharmaceutical diagnostics and imaging businesses, as well as robust services dema...
Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 7....
